Technology
Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) and CE Mark approval of the Emblem Subcutaneous Implantable Defibrillator (S-ICD) system. The Emblem S-ICD system is a treatment option that provides protection for patients at risk of sudden cardiac arrest (SCA), yet leaves the heart and vasculature untouched, minimizing the risk of complications associated with conventional transvenous implantable cardioverter-defibrillators (TV-ICDs).
March 19, 2015
Technology
Philips Healthcare launched IntelliSpace Cardiovascular at the American College of Cardiology (ACC) 2015 meeting. The Web-enabled cardiovascular information system (CVIS) offers a single integrated workspace that produces a holistic view of the patient's care continuum across the entire cardiovascular service line. The new solution provides cardiologists with sophisticated tools for diagnosis and planning of patient cardiovascular care. The system uses an intuitive icon based tab system to easily sort and recognize various types of exams, imaging and reports.
March 19, 2015
Feature
Use of computed tomography coronary angiography (CTA), which provides 3-D images of the heart, coupled with standard care allows doctors to more accurately diagnose coronary artery disease in patients presenting with chest pain. This has led to more appropriate follow-up testing and treatments, according to research presented at the American College of Cardiology (ACC) 2015 Annual Scientific Session. Data also showed a trend toward a lower incidence of heart attacks among the group receiving CT scans, compared to usual care.
March 19, 2015Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Feature
March 19, 2015 — An investigational device that deflects debris away from the brain during transcatheter aortic valve replacement (TAVR) seems to improve in-hospital safety outcomes and cognitive scores at discharge, according to preliminary findings from the small, randomized DEFLECT III study presented at the American College of Cardiology (ACC) 2015 Annual Scientific Session.
March 19, 2015
News
New study results from The Cardiothoracic Surgical Trials Network (CTSN) show the addition of surgical ablation during mitral valve surgery reduces the occurrence of atrial fibrillation in patients.
March 18, 2015
News
SecondOpinionExpert has expanded its online medical second opinions platform by launching an electronic health record (EHR) mobile app for iPhone, iPad and Android devices.
March 18, 2015Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Technology
SST Group Inc. announced a partnership with MPTronic to become the exclusive distributor in the United States and Canada for MPTronic's RDM (Radiation Dosage Monitor).
March 18, 2015
News
NorthStar Medical Radioisotopes LLC will unveil the commercial model of its RadioGenix isotope separation system during three events on March 27 and March 28 at The Keating Hotel in San Diego. The events will be the first public demonstrations of system enhancements directly inspired by recommendations made by nuclear pharmacists during similar events last year.
March 17, 2015
Feature | Gregory Chodaczek, analyst for Sterne Agee
The American College of Cardiology (ACC) hosted its 64th Annual Scientific Session & Expo over the weekend in San Diego, California. Key data from multiple transcatheter aortic valve replacement (TAVR) clinical trials were presented and we believe there was truly no loser between Edwards and Medtronic based on the positive data presented. In addition, St. Jude Medical announced retrospective analysis on CHAMPION data showing significant reduction in mortality rates and heart failure (HF) hospitalizations for heart failure patients with reduced ejection fraction.
March 17, 2015Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Feature
Medtronic plc unveiled new two-year data from the CoreValve U.S. Pivotal High Risk Study, which demonstrated superior two-year survival benefits from transcatheter aortic valve replacement (TAVR) with the CoreValve System compared to surgical aortic valve replacement (SAVR).
March 17, 2015
Feature
Five-year data suggest that the Sapien transcatheter heart valve (Edwards Lifesciences) is a feasible option for patients with severe aortic stenosis deemed to be at high risk for open-heart surgery, though valve leakage was more common with the first-generation valve evaluated in this study than with surgery, according to research from PARTNER I presented at the American College of Cardiology’s (ACC) 2015 Annual Scientific Session.
March 17, 2015
Feature
Heart failure patients with reduced ejection fraction experienced significant HF mortality and hospitalization reductions via guideline-directed medical therapy managed by pulmonary artery pressure monitoring with the CardioMEMS HF System, according to a data analysis from the CHAMPION trial.
March 16, 2015Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Feature
New research from the Minneapolis Heart Institute Foundation (MHIF) finds that percutaneous coronary intervention for heart attacks can still be beneficial for patients who get to their more than 12 hours after their chest pain has started. Timothy Henry, M.D., lead MHIF researcher and director of cardiology at Cedars-Sinai Medical Center in Los Angeles, presented the study results at the 2015 American College of Cardiology (ACC) conference in San Diego.
March 16, 2015
Feature
Results from the PROMISE clinical trial confirmed what many cardiologists and radiologists have long suspected to be true: Coronary computed tomographic angiography (coronary CTA) is extraordinarily effective in accurately diagnosing patients with low to moderate chest pain.
March 16, 2015
Feature
Medtronic plc unveiled the preclinical outcomes of its novel Drug-Filled Stent (DFS) at the 64th Annual Scientific Session of the American College of Cardiology (ACC). The preclinical data showed controlled and efficacious drug elution into the arterial wall without a polymer carrier, while reducing diameter stenosis and achieving complete stent coverage quickly without inflammation. Based on these results, Medtronic plans to initiate a clinical trial in the coming months.
March 16, 2015© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now